Thursday, 05 March 2015

Ebos Group Ordinary Shares

NZX : EBO

10.18
04 Mar 15 00:00
Change:
 0.02
Open:
10.16
High:
10.21
Ask:
10.20
Volume:
135,610
Change(%):
0.20
Prev:
10.20
Low:
10.15
Bid:
10.17
Avg vol:
0
Profile
EBOS Group Limited supplies a range of medical, surgical, retail, dental, and scientific products to the healthcare market in New Zealand and Australia. It operates in two segments, Healthcare and Scientific. The Healthcare segment engages in the sale of healthcare products, as well as in retail healthcare and wholesale activities. The Scientific segment provides laboratory consumables, life sciences equipment, and technical support to industry and research laboratories. Ebos Group Limited serves hospitals, primary care centers, rehabilitation/mobility centers, aged care facilities, and allergists, as well as scientific and consumer markets. The company was formerly known as Ebos Dental & Surgical Supplies LTD and changed its name to Ebos Group Limited in 1986. Ebos Group Limited is headquartered in Christchurch, New Zealand.
Summary
Shares:149,738,700
Issuer:Ebos Group Limited
Solicitor:Chapman Tripp Christchurch
Registry:COMPUTERSHARE INVESTOR SERVICES LIMITED
Auditor:Deloitte Christchurch
Settlement:NZCDC Settlement System
Website:http://www.ebos.co.nz/
Fundamentals
Market Cap:$1,524,339,966
52 wk High:10.58
52 wk Low:8.44
Sector:Intermed & Durables
Div/Yield:9.79
EPS:0.62
Price/Earnings:11.98
NTA:1.04
Address
Ebos Group
108 Wrights Road
PO Box 411
Christchurch,
New Zealand
Latest News
  • EBOS REPORTS STRONG EARNINGS GROWTH FOR HALF YEAR 2015

    11:41 | 25/2/15
    NewsMaker
    EBOS Group Limited today reported strong interim financial results for the half year ending 31 December 2014, showing growth across both its Healthcare and Animal care businesses. more»
  • Multiphasic changes in systemic VEGF following intravitreal injections of ...

    23:24 | 6/2/15
    Nature.com
    Our study is clearly limited by being based on a single paediatric case, but does suggest that systemic exposure needs to be taken into account when considering intravitreal therapy in high-risk groups. An obvious case in point would be the potential ... more»
  • Monte Carlo Fashions lists on the stock exchanges

    22:56 | 19/12/14
    Indiainfoline
    Launched in 1984 as an exclusive woollen brand by Oswal Woollen Mills Limited (“OWML”), one of the Group Companies, Monte Carlo is one of the leading Indian apparel brands based on revenue (Source: Technopak Report, 2014). more»
  • Minister opens new medicine distribution hub

    17:07 | 20/11/14
    Pharmacy News
    Mr Dutton, who officially opened the facility together with Rick Christie (Chairman) and Patrick Davies (CEO) of EBOS Group Limited, the parent company of Symbion, said it would ensure quick access to affordable treatments. “This new state-of-the-art ... more»
  • Ebos looking further afield

    05:01 | 3/11/14
    Stuff.co.nz
    EBOS Group has bought Australian pet food-based Black Hawk Premium Pet Care for $57.8 million, and the company says further acquisitions are on the horizon. more»
Announcements
There are currently no comments on this topic.
Be the first person to Add a Comment...
Add a Comment
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
Global Indices
CodeLastChange
NZ505,877160.28%
COMP4,980280.56%
DJI18,203850.47%
SP5002,108100.45%
DAX11,2801301.14%
FTSE6,889520.74%
NI22518,815120.06%
TWI79.450.010.01%
Currencies
CodeLastChange
EURUSD1.1170.0010.10%
NZDUSD0.75550.00010.01%
AUDUSD0.78190.00020.03%
NZDAUD0.96610.00020.02%